In terms of subtype, 110(46.22%) patients had Luminal A cancer,49(20.59%) patients had Luminal B cancer, 45(18.91%) patients had HER2+/ER- cancer and 34(14.29%) patients had triple-negative cancer. The gene discussed is ERBB2; the disease is cancer.